Developer docs
API playgroundTry for free, no card

Search company profiles

Laboratoire Dermscan

Full company profile

uuid002ndun

Namestring
Laboratoire Dermscan
Legal namestring
EUROFINS LABORATOIRE DERMSCAN
Websiteurl
dermscan.com
Company typeenum
Private
Founded yearint
1990
Descriptiontext

Laboratoire Dermscan (legal entity EUROFINS LABORATOIRE DERMSCAN) is a French contract research organization specializing in pre-clinical and clinical evaluation of cosmetic and pharmaceutical products. Founded in 1990 by Frédérique Girard-Ory and headquartered in Villeurbanne (Lyon), France, the company operates two core service divisions: Eurofins Dermscan (cosmetics and beauty product testing) and Eurofins Pharmascan (pharmaceutical and health product clinical trials). Services span in vitro pre-clinical safety testing (toxicology, microbiology, physicochemical analyses, solar tests) and in vivo clinical studies on volunteer panels, including safety, efficacy, and sensory evaluations using more than 100 measuring devices and 250+ established test protocols.

The company's underlying technology combines accredited laboratory infrastructure with a proprietary volunteer database of approximately 23,000 healthy subjects and patients across multiple countries, spanning infants through seniors and multi-ethnic backgrounds. Electronic case report form (eCRF) data collection, biostatistical analysis, and clinical report writing are integrated within full-service trial management from feasibility through regulatory submission. The company is ISO 9001 certified since 2002, operates in compliance with ISO 14155 and GCP-ICH guidelines, and is approved by France's Agence Régionale de Santé for clinical study conduct.

Commercially, Laboratoire Dermscan operates a B2B professional services model with quote-based project pricing and dedicated sales teams per market segment. It generates revenue by conducting 4,000+ pre-clinical and clinical studies annually for enterprise clients in the cosmetics, pharmaceutical, medical device, dietary supplement, and hygiene product sectors. Since 2018, the company has been a wholly-owned subsidiary of Eurofins Scientific SE, providing access to a global network of approximately 1,000 laboratories in 50+ countries. Own clinical trial centers operate in France (Villeurbanne, Aix-en-Provence), Poland (Gdansk), Tunisia, Thailand (Bangkok), Mauritius, and Spain (Barcelona), with the Espace Volontaires platform supporting volunteer recruitment at compensation rates of €15 to €1,500 per study.

Short descriptiontext

Laboratoire Dermscan is a French CRO operating since 1990 that provides pre-clinical and clinical testing services for cosmetic and pharmaceutical products, serving enterprise clients across Europe, Africa, and Asia via a 23,000-volunteer panel and Eurofins Group affiliation.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersVilleurbanne, France
HQ citystring
Villeurbanne
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices7 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial services, cosmetic product testing, pharmaceutical testing services, in vitro pre-clinical testing, in vivo clinical studies
Industry3 codes
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAE
Central Laboratory & Clinical Trial Testing CROs
SECONDARYHLAGAAAC
Toxicology & Safety Assessment CROs (GLP)
NAICS code2 codes
  • Testing Laboratories and Services54138
  • Medical and Diagnostic Laboratories6215
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Testing Laboratories8734
Product category
Contract Research Organization (CRO) — Clinical Trial & Cosmetic Testing Services
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Clinical Trial Services
TypeProfessional Services
Description

Full-service CRO providing pre-clinical and clinical trial management for pharmaceutical and cosmetic companies, covering all phases from feasibility through regulatory submission to final reporting

dermscan.com
2Cosmetic Testing Services
TypeProfessional Services
Description

Safety, efficacy and sensory evaluation testing for cosmetics and beauty products, including consumer tests and instrumental measurements

dermscan.com
3Volunteer Panel Studies
TypeProfessional Services
Description

Clinical studies conducted on volunteer panels for product evaluation before or after market launch

dermscan.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Others
Pricing details1 tier
1Clinical Study Compensation
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Tax-free allowances ranging from €15 to €1,500 per study, depending on number of appointments and time spent. Annual cap of €6,000 per year per volunteer as per law.

dermscan.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Laboratoire Dermscan is a Contract Research Organization (CRO) that conducts pre-clinical in vitro testing and in vivo clinical studies on volunteer panels to evaluate the safety, efficacy, sensory profile and consumer acceptance of cosmetic and pharmaceutical products. It offers full-service clinical trial management (from feasibility and protocol design through in-life monitoring, data management via eCRF, statistical analysis, clinical report writing and regulatory submission) for cosmetic manufacturers (Eurofins Dermscan) and pharmaceutical/health product companies (Eurofins Pharmascan), including access to multi-ethnic volunteer panels across multiple countries through its own laboratories and the Eurofins global network.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • More than 4,000 studies conducted annually
+2 more records
Product overview1 text field

Eurofins Dermscan Pharmascan operates as a dual-division clinical research organization specializing in cosmetic (Eurofins Dermscan) and pharmaceutical (Eurofins Pharmascan) product evaluation. The company offers pre-clinical and clinical trial services including in vitro testing, in vivo studies on volunteer panels, safety and efficacy assessments, and consumer testing. Services are delivered through owned laboratory sites in France, Poland, Tunisia, Thailand, and Mauritius, integrated within the broader Eurofins network of approximately 1,000 laboratories worldwide. The volunteer recruitment platform (Espace Volontaires) supports subject recruitment across demographic categories from infants to seniors.

Product and service3 records
1Eurofins Dermscan
CategoryCosmetic product testing services (CRO)
Description

Testing services division for cosmetics and beauty products, providing standardized and customized in vitro (toxicology, microbiology, skin/eye irritation, sensitivity, solar tests) and in vivo clinical trials (safety, efficacy via instrumental measurement, sensory evaluation, consumer testing) on volunteer panels for cosmetic manufacturers and beauty brands.

2Eurofins Pharmascan
CategoryPharmaceutical clinical trial services (CRO)
Description

Pharmaceutical and health product clinical trials division offering pre-clinical and clinical trial management (CRO/CRC) in healthcare facilities, with full-service support from feasibility and protocol design through monitoring, eCRF-based data management, statistical analysis, and clinical report writing for regulatory submission, in compliance with ICH-GCP and ISO 14155.

3Espace Volontaires
CategoryClinical study volunteer recruitment
Description

Volunteer panel program that recruits and manages healthy subjects and patients (infants, children, adolescents, adults, seniors across multi-ethnic backgrounds) to participate in the company's clinical studies and consumer tests, with compensation of €15 to €1,500 per study (capped at €6,000/year tax-free per French law).

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-01-01
Description

Eurofins Dermscan Pharmascan conducted a clinical study for the Naos Group evaluating the interest of a dermocosmetic product in improving quality of life for diabetic and dialysis patients suffering from skin dryness and pruritus. Study conducted with medical teams in Poland (Eurofins Dermscan Poland) and Mauritius (Insight Research).

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-01-01
Description

Pierre Fabre Dermo-Cosmetique utilized Eurofins Dermscan Pharmascan's ability to recruit subjects with specific criteria (erythematotelangiectatic or papulopustular rosacea) in Poland for a clinical study evaluating product benefits. Results published in JEADV.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers6 records
TypeBroad incumbent
Description

Global testing, inspection and certification company with a cosmetics and personal care testing practice. Comparable to Dermscan's cosmetic product testing, sensory evaluation, and claims-substantiation services.

TypeBroad incumbent
Description

Major global CRO providing clinical research services across all phases. Comparable as a clinical CRO competitor targeting pharma and consumer health sponsors.

TypeBroad incumbent
Description

Testing and quality assurance provider with consumer products and cosmetics testing labs. Comparable for cosmetic safety, efficacy, and regulatory testing services targeting beauty and personal care brands.

TypeBroad incumbent
Description

World's largest CRO offering full-service Phase I-IV clinical trial management across pharma and consumer health. Comparable to Pharmascan's full-service clinical CRO model, though at vastly greater scale and broader therapeutic coverage.

TypeBroad incumbent
Description

Global testing, inspection and certification group with consumer product testing capabilities including cosmetics. Overlaps with Dermscan on safety/efficacy/claims testing for beauty products.

TypeBroad incumbent
Description

Global CRO with strong safety assessment, preclinical and clinical trial capabilities. Directly comparable to Dermscan-Pharmascan's combined pre-clinical (in vitro toxicology) and clinical offering, especially for cosmetics and personal care clients.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Laboratoire Dermscan

Contract Research Organization (CRO) — Clinical Trial & Cosmetic Testing Servicesdermscan.com

Laboratoire Dermscan is a French CRO operating since 1990 that provides pre-clinical and clinical testing services for cosmetic and pharmaceutical products, serving enterprise clients across Europe, Africa, and Asia via a 23,000-volunteer panel and Eurofins Group affiliation.

What Laboratoire Dermscan does

Laboratoire Dermscan (legal entity EUROFINS LABORATOIRE DERMSCAN) is a French contract research organization specializing in pre-clinical and clinical evaluation of cosmetic and pharmaceutical products. Founded in 1990 by Frédérique Girard-Ory and headquartered in Villeurbanne (Lyon), France, the company operates two core service divisions: Eurofins Dermscan (cosmetics and beauty product testing) and Eurofins Pharmascan (pharmaceutical and health product clinical trials). Services span in vitro pre-clinical safety testing (toxicology, microbiology, physicochemical analyses, solar tests) and in vivo clinical studies on volunteer panels, including safety, efficacy, and sensory evaluations using more than 100 measuring devices and 250+ established test protocols.

The company's underlying technology combines accredited laboratory infrastructure with a proprietary volunteer database of approximately 23,000 healthy subjects and patients across multiple countries, spanning infants through seniors and multi-ethnic backgrounds. Electronic case report form (eCRF) data collection, biostatistical analysis, and clinical report writing are integrated within full-service trial management from feasibility through regulatory submission. The company is ISO 9001 certified since 2002, operates in compliance with ISO 14155 and GCP-ICH guidelines, and is approved by France's Agence Régionale de Santé for clinical study conduct.

Commercially, Laboratoire Dermscan operates a B2B professional services model with quote-based project pricing and dedicated sales teams per market segment. It generates revenue by conducting 4,000+ pre-clinical and clinical studies annually for enterprise clients in the cosmetics, pharmaceutical, medical device, dietary supplement, and hygiene product sectors. Since 2018, the company has been a wholly-owned subsidiary of Eurofins Scientific SE, providing access to a global network of approximately 1,000 laboratories in 50+ countries. Own clinical trial centers operate in France (Villeurbanne, Aix-en-Provence), Poland (Gdansk), Tunisia, Thailand (Bangkok), Mauritius, and Spain (Barcelona), with the Espace Volontaires platform supporting volunteer recruitment at compensation rates of €15 to €1,500 per study.

Laboratoire Dermscan firmographics

Firmographics
Name
Laboratoire Dermscan
Legal name
EUROFINS LABORATOIRE DERMSCAN
Website
https://dermscan.com
Company type
Private
Founded year
1990
Operating status
Operating
Headcount range
101–250 employees
Short description
Laboratoire Dermscan is a French CRO operating since 1990 that provides pre-clinical and clinical testing services for cosmetic and pharmaceutical products, serving enterprise clients across Europe, Africa, and Asia via a 23,000-volunteer panel and Eurofins Group affiliation.
Ownership category
akta.pro rank

Laboratoire Dermscan industry classification

Industry
Product category
Contract Research Organization (CRO) — Clinical Trial & Cosmetic Testing Services
NAICS
Testing Laboratories and Services (54138), Medical and Diagnostic Laboratories (6215)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAE
Central Laboratory & Clinical Trial Testing CROs
SECONDARYHLAGAAAC
Toxicology & Safety Assessment CROs (GLP)

Keywords

  • Clinical trial services
  • Cosmetic product testing
  • Pharmaceutical testing services
  • In vitro pre-clinical testing
  • In vivo clinical studies

Where Laboratoire Dermscan is headquartered

Location

Headquarters

HQ city
Villeurbanne
HQ country
France
HQ region
Europe

Offices7 records

Markets served

Laboratoire Dermscan business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Clinical Trial Services: Full-service CRO providing pre-clinical and clinical trial management for pharmaceutical and cosmetic companies, covering all phases from feasibility through regulatory submission to final reporting
  2. Cosmetic Testing Services: Safety, efficacy and sensory evaluation testing for cosmetics and beauty products, including consumer tests and instrumental measurements
  3. Volunteer Panel Studies: Clinical studies conducted on volunteer panels for product evaluation before or after market launch

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goClinical Study Compensation

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Laboratoire Dermscan product offering

Product offering

Core offering

Laboratoire Dermscan is a Contract Research Organization (CRO) that conducts pre-clinical in vitro testing and in vivo clinical studies on volunteer panels to evaluate the safety, efficacy, sensory profile and consumer acceptance of cosmetic and pharmaceutical products. It offers full-service clinical trial management (from feasibility and protocol design through in-life monitoring, data management via eCRF, statistical analysis, clinical report writing and regulatory submission) for cosmetic manufacturers (Eurofins Dermscan) and pharmaceutical/health product companies (Eurofins Pharmascan), including access to multi-ethnic volunteer panels across multiple countries through its own laboratories and the Eurofins global network.

Product overview

Eurofins Dermscan Pharmascan operates as a dual-division clinical research organization specializing in cosmetic (Eurofins Dermscan) and pharmaceutical (Eurofins Pharmascan) product evaluation. The company offers pre-clinical and clinical trial services including in vitro testing, in vivo studies on volunteer panels, safety and efficacy assessments, and consumer testing. Services are delivered through owned laboratory sites in France, Poland, Tunisia, Thailand, and Mauritius, integrated within the broader Eurofins network of approximately 1,000 laboratories worldwide. The volunteer recruitment platform (Espace Volontaires) supports subject recruitment across demographic categories from infants to seniors.

Differentiator

Problem solved

Functional benefit

Products and services

  • Eurofins Dermscan Testing services division for cosmetics and beauty products, providing standardized and customized in vitro (toxicology, microbiology, skin/eye irritation, sensitivity, solar tests) and in vivo clinical trials (safety, efficacy via instrumental measurement, sensory evaluation, consumer testing) on volunteer panels for cosmetic manufacturers and beauty brands.
  • Eurofins Pharmascan Pharmaceutical and health product clinical trials division offering pre-clinical and clinical trial management (CRO/CRC) in healthcare facilities, with full-service support from feasibility and protocol design through monitoring, eCRF-based data management, statistical analysis, and clinical report writing for regulatory submission, in compliance with ICH-GCP and ISO 14155.
  • Espace Volontaires Volunteer panel program that recruits and manages healthy subjects and patients (infants, children, adolescents, adults, seniors across multi-ethnic backgrounds) to participate in the company's clinical studies and consumer tests, with compensation of €15 to €1,500 per study (capped at €6,000/year tax-free per French law).

Quantifiable outcome

  • More than 4,000 studies conducted annually
  • +2 more outcomes

Companies that use Laboratoire Dermscan

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Laboratoire Dermscan technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Laboratoire Dermscan partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Naos GroupcoreStrategic or Co-development Partner · 1 January 2022Eurofins Dermscan Pharmascan conducted a clinical study for the Naos Group evaluating the interest of a dermocosmetic product in improving quality of life for diabetic and dialysis patients suffering from skin dryness and pruritus. Study conducted with medical teams in Poland (Eurofins Dermscan Poland) and Mauritius (Insight Research).
  • Pierre Fabre Dermo-CosmetiquecoreStrategic or Co-development Partner · 1 January 2022Pierre Fabre Dermo-Cosmetique utilized Eurofins Dermscan Pharmascan's ability to recruit subjects with specific criteria (erythematotelangiectatic or papulopustular rosacea) in Poland for a clinical study evaluating product benefits. Results published in JEADV.

Scale indicators7 records

Recent moves7 records

Expansion highlights4 records

Laboratoire Dermscan competitors and assessment

Company assessment

Broad incumbents

  • SGS: Global testing, inspection and certification company with a cosmetics and personal care testing practice. Comparable to Dermscan's cosmetic product testing, sensory evaluation, and claims-substantiation services.
  • ICON plc: Major global CRO providing clinical research services across all phases. Comparable as a clinical CRO competitor targeting pharma and consumer health sponsors.
  • Intertek: Testing and quality assurance provider with consumer products and cosmetics testing labs. Comparable for cosmetic safety, efficacy, and regulatory testing services targeting beauty and personal care brands.
  • IQVIA: World's largest CRO offering full-service Phase I-IV clinical trial management across pharma and consumer health. Comparable to Pharmascan's full-service clinical CRO model, though at vastly greater scale and broader therapeutic coverage.
  • Bureau Veritas: Global testing, inspection and certification group with consumer product testing capabilities including cosmetics. Overlaps with Dermscan on safety/efficacy/claims testing for beauty products.
  • Charles River Laboratories: Global CRO with strong safety assessment, preclinical and clinical trial capabilities. Directly comparable to Dermscan-Pharmascan's combined pre-clinical (in vitro toxicology) and clinical offering, especially for cosmetics and personal care clients.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Laboratoire Dermscan social profiles

Digital presence

Laboratoire Dermscan compliance and trust

Trust signal

Compliance3 records

Laboratoire Dermscan financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Laboratoire Dermscan leadership team

Management profile

Number of profiles

Profiles1 record

Laboratoire Dermscan subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

Laboratoire Dermscan funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Laboratoire Dermscan M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laboratoire Dermscan

What does Laboratoire Dermscan do?

Laboratoire Dermscan is a Contract Research Organization (CRO) that conducts pre-clinical in vitro testing and in vivo clinical studies on volunteer panels to evaluate the safety, efficacy, sensory profile and consumer acceptance of cosmetic and pharmaceutical products. It offers full-service clinical trial management (from feasibility and protocol design through in-life monitoring, data management via eCRF, statistical analysis, clinical report writing and regulatory submission) for cosmetic manufacturers (Eurofins Dermscan) and pharmaceutical/health product companies (Eurofins Pharmascan), including access to multi-ethnic volunteer panels across multiple countries through its own laboratories and the Eurofins global network.

Is Laboratoire Dermscan a public or private company?

Laboratoire Dermscan is a private company. It is classified as corporate owned and is currently operating.

When was Laboratoire Dermscan founded?

Laboratoire Dermscan was founded in 1990. It employs 101 to 250 people.

Where is Laboratoire Dermscan based?

Laboratoire Dermscan is headquartered in Villeurbanne, France, in the Europe region.

How does Laboratoire Dermscan make money?

Three revenue lines are on record. Clinical Trial Services are the primary driver. The others are cosmetic Testing Services and volunteer Panel Studies.

Who are Laboratoire Dermscan's main competitors?

Broad incumbents on record are SGS, ICON plc, Intertek, IQVIA, Bureau Veritas and Charles River Laboratories.

Does Laboratoire Dermscan have an API?

No public API is recorded for Laboratoire Dermscan.

What industry is Laboratoire Dermscan in?

Laboratoire Dermscan's product category is Contract Research Organization (CRO) — Clinical Trial & Cosmetic Testing Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAE, Central Laboratory & Clinical Trial Testing CROs. Its NAICS code is 54138 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Cosmetics BusinessClinical evaluation at the forefront of the Comet CongressDermscan is focusing on atmospheric pollution's effects on skin, including dullness, inflammation, and barrier damage. At the COMET Congress, it presented in vivo trials evaluating tissue oxygenation and protection against microparticules. The company has only conducted in vitro studies on pollutants so far.Cosmetics BusinessMeet Dermscan at in-cosmetics Paris 2016, booth Q118Dermscan will be at booth Q118 at in-cosmetics Paris 2016, an event for cosmetic ingredients suppliers and formulators. The company invites attendees to contact its sales team and technical project managers for advice on clinical trial projects.Cosmetics BusinessClinical testing are on a rollDERMSCAN Group celebrated its 25th anniversary in early 2015, highlighting its ISO-certified and GLP-approved in vivo testing laboratories in France, Poland, Thailand, and Tunisia, plus an in vitro lab in Poland. The company provides clinical safety, efficacy, and sensory trials across the value chain.Cosmetics BusinessAnalysis of the hydration distribution on skin/hair surfaceDermscan has added the Moisture Map MM100 device to its lineup, which maps hydration distribution on skin and hair surfaces. The device uses a capacity sensor, with dry zones appearing light and humid zones darker. Image processing software provides topographical measurements including profile, density, and anisotropy index.Cosmetics BusinessThe secret of sensory test at Dermscan with expert panelistsDermscan's sensory department employs 15 trained panelists who conduct sniff-tests, QDA profiles, and complexion assessments. The panelists, some loyal for over 20 years, use standardized equipment to quantify differences in perspiration odor or fragrance. The goal is to obtain homogeneous results.Cosmetics BusinessDermscan to exhibit at NYSCC Suppliers’ DayDermscan will exhibit its latest innovations at the NYSCC Suppliers' Day, a major American cosmetic ingredients exhibition. The company will attend to exchange and advise on clinical trial projects for new products, raw materials, ingredients, and food supplements. Booth T506 is listed, with contact details provided.Cosmetics BusinessImmediate and contact free evaluation of the skin/hair temperatureDermscan acquired a FLUKE Ti300 infrared camera to enable contact-free, real-time skin and hair temperature evaluation. The device measures radiant heat to quantify effects on skin vascularization, cooling or heating actions, anti-cellulite efficacy, and protective effects of hair products.Cosmetics BusinessIn Vitro study of the endocrine disruptorsPalmer Research, the in vitro laboratory of Dermscan, now offers endocrine disruption testing using the YAS and YES yeast assays. The tests, conducted on genetically modified Saccharomyces cerevisiae, measure colorimetric reactions at 570 nm to detect interactions with androgen or estrogen receptors. The service aims to demonstrate that products do not alter hormonal activity.Cosmetics BusinessDermscan introduces HRIPT under dermatological controlDermscan introduces HRIPT, a clinical test under dermatological control to confirm that repeated applications of a cosmetic or pharmaceutical product do not induce delayed contact allergy reactions. The test also assesses irritating and sensitising potential, enabling claims of hypoallergenic features.Cosmetics BusinessTesting the nutricosmetic claimsDermscan Group is proposing tests for nutricosmetic products, adapting existing protocols to evaluate tolerance, efficacy, and sensorial characteristics. The company aims to capitalize on the growing trend in nutricosmetics and functional foods, according to president Frédérique Girard.